LomMedical video: CEO Herbert Towning

In brief: We have not published new content for a while, but I thought this was a great opportunity to wish our readers a Happy New Year and all the best for 2018.

In this entry we give you the opportunity to hear LomMedical’s Chairman’s thoughts and plans for 2018.
He outlines why the LomMedical line of products – safety syringes – is a game changer for both health professionals and patients.

LomMedical’s auto-disable syringes – also called reuse prevention syringes or RUPs by the World Health Organization or WHO  – are specifically designed for single use. It has a patented mechanism that blocks the barrel once used, thereby assuring single-use of the needle.

The first challenge we had for making this video was to coordinate our video team, corporate communications and the CEO to Zurich just before Christmas. Once we had a date – December 22, all was set to get going.

Patrizia Sinistra show sHerbert Towning what we shot so far.

Patrizia Sinistra shows Herbert Towning what we shot so far.

We wanted Herb Towning to address 3 important points in this video:

  1. What makes the LomMedical technology a possible game changer?
  2. What advantages does LomMedical’s technology offer to doctors, health care professionals, insurers and patients?
  3. What are LomMedical’s plans for getting FDA approval during 2018 and moving to market?

Even though we had worked hard for several hours, there was enough time to have a laugh or two.

Urs E. Gattiker and Herbert Towning having fun making movies.

Urs E. Gattiker and Herbert Towning having fun making movies.

Plans for 2018

Of course, LomMedical will continue to develop their pipeline of products.

The World Health Organization (WHO) has stipulated the following:

Governments
By 2020 transition to the exclusive use, where appropriate, of safety-engineered injection devices with re-use prevention and sharps (needle) injury prevention.
Making all injections safe. World Health Organizationn 2015.

Fact 1. The LomMedical line of safety-engineered syringes prevent reuse and sharps (needle) injury as a standard function.
Fact 2. Producing a large amount of syringes is the next critical step. This is another crucial step required to get things ready for our FDA application.

In this video, Herb Towning explains how LomMedical safety-engineered syringes have the potential to drastically reduce injuries for health care professionals.

PS. The video is in English. Duration is just about 4 minutes. Interesting material. Just watch.

If you want to participate in our project, please feel free to get in touch with us via e-mail: dUlansky@LomLabs.ca (just click this link)

Incidentally, LomMedical has already started to put Herb’s strategy in place. Hard work but it is needed, of course.

Join the discussion: Your opinion matters

We shared some information here:Here are our questions to you, let us know what you think.

  • Have you or one of your relatives had an injection recently?  What did you like the least or the most?
  • Do you know of a case where a health professional was injured, while giving an injection?
  • What other question do you have that we might not have answered in our video #CEOsecrets ?
Showing 4 comments
  • Reply

    We made a blog entry about making this video because it shows that it takes a lot of

    – humor
    – stamina, and
    – perseverance

    Enjoy — Making of the LomMedical video: A look behind the scenes

    Urs
    #BlogRank

  • Jane Oxenbury
    Reply

    Not much new here.
    What is the timeline for the product to be approved and ready for sale to a medical company?

    I know there have been delays but there was talk of it be manufactured in December. When can we expect return on our investment?

    I know this takes time but feel the repeat of information but yet another person is not encouraging.

    • Urs E. Gattiker
      Reply

      Dear Jane

      Thanks for your comment. I understand very well that you want to see progress and recoup your investment, of course. So do I.

      For me, as a shareholder what was new were the plans that Herb outlines for 2018. I did not know these before the video was done. I find very interesting that LomMedical strives to get:

      1. FDA clearance or approval hopefully by Summer/Fall 2018 (that is fast) … the European clearance will take a while longer (apparently they just take longer – as we know, c’est la vie),
      2. company management in place, to enable the firm to streamline operations and realise the plans for 2018, and
      3. sell product starting in late 2018

      I also hope that the first 3,000 syringes are being produced pretty quick this January. Most importantly, I want the tests on a selection of these produced safety syringes to tell us that all is working according to the regulations that must be met.

      This production run and subsequent tests of this industrially produced larger batch of retractable syringes is a required regulatory step. If these tests are successful and according to plan, than we are ready to submit the application to the FDA. These tests provide the necesssary data to show that our product is safe.

      Only this way can we expect to get clearance. This should enable us to produce large batches of our retractable safety syringe and sell it globally.

      That delays happen during Christmas Holidays is not that unusual.

      So I myself am pretty confident that that within the next few weeks the company will report about another milestone that has been reached.

      I hope this information is useful to you.
      Thanks and please stay tuned.

      Urs

      • Reply

        Addendum
        This might be a minor point but I find it interesting so I put it in here:
        1. By early 2013 this company had some plans, maybe even a patent application.
        What it lacked was a perfectly working prototype.
        2. We all know from experience in the medical equipment and technology area that bringing an idea from paper to the marketplace is the final challenge. Often innovators do not manage and the product is never being sold.

        We have made big strides the last 4 years.
        I have seen so many failures…. after much money was invested in the medical equipment and technology area, just because at the end, the product could not be produced economically or did not function according to plans.
        Of course, in the medical equipment and technology domain, things must work perfectly, since a patient’s well being if not life may depend on it.
        A blue Windows screen – a fatal error occurred, please reboot your machine – will most certainly not do.

        In LomMedical’s case we are moving toward the finishing line fast, which is:
        ===> getting this baby into the hands of and used by medical practitioners.

Leave a Comment

Ralph Woloschuk - LomMedical - visiting the KDL stand in Duesseldorf.Showing the latest version of the LomMedical syringe.